Inventor · West Jupiter, FL, US

William R. Roush

42Patents
8h-index
42Co-inventors
75Inventor score

Filing activity: Aug 14, 1998 → Oct 17, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US6133308A Synthesis of clasto-lactacystin beta-lactone and analogs thereof Chemistry; Metallurgy 55 Expired
US6294560A Synthesis of clasto-lactacystin .beta.-lactone and analogs thereof Chemistry; Metallurgy 54 Expired
US6849743B2 Synthesis of clasto-lactacystin β-lactone and analogs thereof Chemistry; Metallurgy 53 Expired
US6794516B2 Synthesis of clasto-lactacystin &bgr;-lactone and analogs thereof Chemistry; Metallurgy 52 Expired
US6566553B2 Synthesis of clasto-lactacystin &bgr;-lactone and analogs thereof Chemistry; Metallurgy 27 Expired
US10556903B2 NLRP3 modulators Emerging Cross-Sectional Technologies 11 Active
US10533007B2 NLRP3 modulators Human Necessities 10 Active
US10533005B2 NLRP3 modulators Human Necessities 9 Active
US10604542B2 Cyclic dinucleotides for treating conditions associated with sting activity such as cancer Human Necessities 4 Active
US10654816B2 Compounds and compositions for treating conditions associated with NLRP activity Chemistry; Metallurgy 2 Active
US10329303B2 Heterocyclic inhibitors of monocarboxylate transporter Chemistry; Metallurgy 2 Active
US10961270B2 Compounds and compositions for treating conditions associated with sting activity Human Necessities 2 Active
US11072612B2 NLRP3 modulators Emerging Cross-Sectional Technologies 1 Active
US11344543B2 NLRP3 modulators Chemistry; Metallurgy 1 Active
US10851113B2 Heterocyclic inhibitors of monocarboxylate transporters Chemistry; Metallurgy 1 Active
US11203579B2 Compounds and compositions for treating conditions associated with NLRP activity Chemistry; Metallurgy 1 Active
US9493464B2 Wee1 degradation inhibitors Chemistry; Metallurgy 1 Active
US11724992B2 Compounds and compositions for treating conditions associated with NLRP activity Chemistry; Metallurgy 0 Active
US11447460B2 Compounds and compositions for treating conditions associated with NLRP activity Chemistry; Metallurgy 0 Active
US11618749B2 Compounds and compositions for treating conditions associated with STING activity Chemistry; Metallurgy 0 Active
US10723756B2 Cyclic dinucleotides for treating conditions associated with STING activity such as cancer Human Necessities 0 Active
US11731934B2 HDAC inhibitor compounds and methods of treatment Chemistry; Metallurgy 0 Active
US10485804B2 Therapeutic targeting of casein kinase 1δ in breast cancer General 0 Revoked
US11370763B2 Compounds and compositions for treating conditions associated with NLRP activity Chemistry; Metallurgy 0 Active
US12152018B2 Compounds and compositions for treating conditions associated with STING activity Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.